home / stock / nova:cc / nova:cc news


NOVA:CC News and Press, Nova Mentis Life Science Corp. From 04/14/22

Stock Information

Company Name: Nova Mentis Life Science Corp.
Stock Symbol: NOVA:CC
Market: CNQC

Menu

NOVA:CC NOVA:CC Quote NOVA:CC Short NOVA:CC News NOVA:CC Articles NOVA:CC Message Board
Get NOVA:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

NOVA:CC - BioMed Momentum: VERU, NMLSF, PHRX, CRXT; Life Sciences Leaders Report Latest Advances in New Drug Development for COVID-19, Cancers, Glaucoma, and Autism

NEW YORK, April 14, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Veru Inc. (NASDAQ: VERU), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Clarus Therapeutics (NASDAQ...

NOVA:CC - Healthcare Breakthroughs: Atai, Nova Mentis, PolarityTE, and LIXTE; Biomed Leaders Report Latest Advances in Regenerative Tissue Technology, Psychedelics, and New Therapeutics for Autism, Mental Health and Cancers

NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: PolarityTE, Inc. (NASDAQ: PTE), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), atai Life Sciences N....

NOVA:CC - BioMed Stocks On the Move: Nova Mentis, PolarityTE, Biodesix and PharmaDrug; Life Sciences Leaders Report Latest Advances in Regenerative Tissue Technology, New Drugs for Cancers, Glaucoma, and Autism, and Diagnostics.

NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: PolarityTE, Inc. (NASDAQ: PTE) Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Biodesix, Inc....

NOVA:CC - Healthcare Breakthroughs: Veru, Nova Mentis, Phio, and PharmaDrug; Visionary CEOs Report Latest Advances in New Drug Development for COVID-19, Cancers, Glaucoma, and Autism

NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Phio Pharmaceuticals (NASDAQ: PHIO), Veru Inc...

NOVA:CC - BioMed Leaders: Hoth Therapeutics, Nova Mentis Life Sciences, Tonix Pharmaceuticals, and MedAvail; Visionary CEOs Report Latest Advances in Novel Therapeutics for Autism, Cancer, and Fibromyalgia, and Drug Affordability.

NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Hoth Therapeutics (NASDAQ: HOTH), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Tonix Pharm...

NOVA:CC - Nova Mentis to Produce Psilocybin Capsules for Phase 2A Clinical Study

Nova Mentis to Produce Psilocybin Capsules for Phase 2A Clinical Study Canada NewsWire Manufacturing Contract with the Toronto Institute of Pharmaceutical Technology VANCOUVER, BC , April 7, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE...

NOVA:CC - Nova Mentis Begins Enrollment in North American Autism Study

Nova Mentis Begins Enrollment in North American Autism Study Canada NewsWire VANCOUVER, BC , March 23, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global...

NOVA:CC - Nova Mentis Announces Closing of Non-Brokered Financing

Nova Mentis Announces Closing of Non-Brokered Financing Canada NewsWire VANCOUVER, BC , March 15, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in fi...

Previous 10 Next 10